DNA X

DNA X Diluted EPS

The Diluted Earnings per Share of DNA X (SONM) as of Oct 16, 2026 is -13.88 USD. In the previous year, Diluted Earnings per Share was -121.52 USD — a change of -88.58% (higher).

Diluted EPS

-13.88USD

YoY

-88.58%

Last updated:

Diluted Earnings per Share of DNA X is 2025 -13.88 USD. Diluted Earnings per Share of DNA X was 2024 -121.52 USD. It decreases by -88.58% higher compared to the previous year.

The DNA X Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
11.96 USD
Jan 1, 2019
-2,266.14 USD
Jan 1, 2020
-813.37 USD
Jan 1, 2021
-369.64 USD
Jan 1, 2022
-62.19 USD
Jan 1, 2023
-0.38 USD
Jan 1, 2024
-121.52 USD
Jan 1, 2025
-13.88 USD
The DNA X Diluted EPS history
YEARDiluted EPSYoY
-13.88USD-88.58%
-121.52USD+32,209.96%
-0.38USD-99.40%
-62.19USD-83.17%
-369.64USD-54.55%
-813.37USD-64.11%
-2,266.14USD-19,052.53%
11.96USD-289.61%
-6.31USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DNA X Stock analysis

What does DNA X do? DNA X Inc, trading under the ticker SONM, is a U.S.-based company headquartered in Austin. Founded in 2019, it went public on May 10, 2019. The company operates in the Information Technology sector, specifically within the Technology industry. DNA X Inc employs four people, according to the provided data. Its website is http://www.sonimtech.com. The company focuses on developing mission-critical smartphone-based solutions for workers operating in extreme, hazardous, and isolated environments. However, the source description provided contains conflicting information, including an employee count of 403 and details about product lines such as Sonim XP8, Sonim XP5s, and Sonim XP3, which are not confirmed by the user-provided data. The user message specifies that the company is DNA X Inc, not Sonim Technologies, and the employee count is four, not 403. The source description also incorrectly states the company's name and other details. Therefore, the factual description is limited to the information provided: a small Austin-based technology company with four employees, an IPO in 2019, and a website. No further details about products, services, or industry specifics can be confirmed from the user message alone. DNA X is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DNA X stock

Diluted Earnings per Share of DNA X is -13.88 USD in 2025.

Diluted Earnings per Share of DNA X changed from -121.52 USD to -13.88 USD, representing a -88.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share DNA X since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — DNA X

All Key Metrics — DNA X